American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients.

Select Content Type
Clinical Guidelines
Authored By
Neofytos D, Steinbach WJ, Hanson K, Carpenter PA, Papanicolaou GA, Slavin MA
Authored On
Interests
Infectious Disease & Vaccines
Obstetrics & Gynecology
Speciality
Obstetrics & Gynecology
Infectious Disease & Vaccines
Book Detail
volume
29
ISSN
2666-6367
Publication Date
Actions
Download in App
Event Data
{"article_title":"American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients.","author":"Neofytos D, Steinbach WJ, Hanson K, Carpenter PA, Papanicolaou GA, Slavin MA","journal_title":"Transplantation and cellular therapy","issn":"2666-6367","isbn":"","publication_date":"2022 Aug","volume":"29","issue":"4","first_page":"222","page_count":"","accession_number":"36649748","doi":"10.1016\/j.jtct.2023.01.011","publisher":"Elsevier Inc","doctype":"Practice Guideline","subjects":"United States; Hematopoietic Stem Cell Transplantation adverse effects; Candidiasis, Invasive epidemiology; Candidiasis, Invasive therapy; Adult; Humans; Child; United States epidemiology; Transplant Recipients","interest_area":["Infectious Disease & Vaccines"," Obstetrics & Gynecology"],"abstract":"The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A completely new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and then answered FAQs and finalized topics with harmonized recommendations made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. This sixth guideline in the series focuses on invasive candidiasis (IC) with FAQs to address epidemiology, clinical diagnosis, prophylaxis, and treatment of IC, plus special considerations for pediatric, cord blood, haploidentical, and T cell-depleted HCT recipients and chimeric antigen receptor T cell recipients, as well as future research directions. Copyright \u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36649748&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":false,"isSAML":true,"additionalInfo":{"Authored_By":"Neofytos D, Steinbach WJ, Hanson K, Carpenter PA, Papanicolaou GA, Slavin MA","Journal_Info":"Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE","Publication_Type":"Practice Guideline; Research Support, N.I.H., Extramural; Journal Article","Published_Date":"2023-04-01","Source":"Transplantation and cellular therapy [Transplant Cell Ther] 2023 Apr; Vol. 29 (4), pp. 222-227. Date of Electronic Publication: 2023 Jan 14.","Languages":"English","Electronic_ISSN":"2666-6367","MeSH_Terms":"Hematopoietic Stem Cell Transplantation*\/adverse effects , Candidiasis, Invasive*\/epidemiology , Candidiasis, Invasive*\/therapy, Adult ; Child ; United States\/epidemiology ; Humans ; Candidiasis ; Transplant Recipients","Subjects":"Adult, Child, United States epidemiology, Humans, Candidiasis, Transplant Recipients, Hematopoietic Stem Cell Transplantation adverse effects, Candidiasis, Invasive epidemiology, Candidiasis, Invasive therapy","Title_Abbreviations":"Transplantation and cellular therapy","Volume":"29"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"36649748","RelevancyScore":"845","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"845.46630859375"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=36649748&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/dx.doi.org\/doi:10.1016\/j.jtct.2023.01.011"}
ISSN
2666-6367
IS_Ebsco
true
Upload Link
https://search.ebscohost.com/login.aspx?direct=true&db=mdl&AN=36649748&authtype=shib&custid=ns346513&group=main&profile=eds
Additional Info
["Neofytos D, Steinbach WJ, Hanson K, Carpenter PA, Papanicolaou GA, Slavin MA","Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE","Practice Guideline; Research Support, N.I.H., Extramural; Journal Article","2023-04-01","Transplantation and cellular therapy [Transplant Cell Ther] 2023 Apr; Vol. 29 (4), pp. 222-227. Date of Electronic Publication: 2023 Jan 14.","English","2666-6367","Hematopoietic Stem Cell Transplantation*\/adverse effects , Candidiasis, Invasive*\/epidemiology , Candidiasis, Invasive*\/therapy, Adult ; Child ; United States\/epidemiology ; Humans ; Candidiasis ; Transplant Recipients","Adult, Child, United States epidemiology, Humans, Candidiasis, Transplant Recipients, Hematopoietic Stem Cell Transplantation adverse effects, Candidiasis, Invasive epidemiology, Candidiasis, Invasive therapy","Transplantation and cellular therapy","29"]
Description
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A completely new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and then answered FAQs and finalized topics with harmonized recommendations made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. This sixth guideline in the series focuses on invasive candidiasis (IC) with FAQs to address epidemiology, clinical diagnosis, prophylaxis, and treatment of IC, plus special considerations for pediatric, cord blood, haploidentical, and T cell-depleted HCT recipients and chimeric antigen receptor T cell recipients, as well as future research directions.<br /> (Copyright © 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.)
Published Date